Whole-body and Single-Photon Emission Computed Tomography/Computed Tomography Postpeptide Receptor Alpha Radionuclide Therapy Images of Actinium 225-Tetraazacyclododecanetetraacetic Acid–Octreotide as a Primary Modality of Treatment in a Patient with Advanced Rectal Neuroendocrine Tumor with Metastases

Somatostatin receptor-targeted alpha radionuclide therapies have been introduced including actinium-225 labeled tetraazacyclododecanetetraacetic acid–octreotide (Ac-225 DOTATATE) for advanced metastatic neuroendocrine tumors (NET). Very limited data are available on the posttherapy imaging using Ac-...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamaleshwaran, Koramadai Karuppusamy, Suneelkumar, Malipedda, Madhusairam, Raghunathan, Radhakrishnan, Edathuruthy Kalarikal, Arunpandiyan, Soundararajan, Arnold, Vasumathi Jayaraj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537929/
https://www.ncbi.nlm.nih.gov/pubmed/33082679
http://dx.doi.org/10.4103/ijnm.IJNM_58_20
_version_ 1783590764705480704
author Kamaleshwaran, Koramadai Karuppusamy
Suneelkumar, Malipedda
Madhusairam, Raghunathan
Radhakrishnan, Edathuruthy Kalarikal
Arunpandiyan, Soundararajan
Arnold, Vasumathi Jayaraj
author_facet Kamaleshwaran, Koramadai Karuppusamy
Suneelkumar, Malipedda
Madhusairam, Raghunathan
Radhakrishnan, Edathuruthy Kalarikal
Arunpandiyan, Soundararajan
Arnold, Vasumathi Jayaraj
author_sort Kamaleshwaran, Koramadai Karuppusamy
collection PubMed
description Somatostatin receptor-targeted alpha radionuclide therapies have been introduced including actinium-225 labeled tetraazacyclododecanetetraacetic acid–octreotide (Ac-225 DOTATATE) for advanced metastatic neuroendocrine tumors (NET). Very limited data are available on the posttherapy imaging using Ac-225 DOTATATE therapy in metastatic NET. We present Ac-225 single-photon emission computed tomography/computed tomography images of a 72-year-old patient diagnosed as a case of advanced rectal NET treated primarily with Ac-225 DOTATATE.
format Online
Article
Text
id pubmed-7537929
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-75379292020-10-19 Whole-body and Single-Photon Emission Computed Tomography/Computed Tomography Postpeptide Receptor Alpha Radionuclide Therapy Images of Actinium 225-Tetraazacyclododecanetetraacetic Acid–Octreotide as a Primary Modality of Treatment in a Patient with Advanced Rectal Neuroendocrine Tumor with Metastases Kamaleshwaran, Koramadai Karuppusamy Suneelkumar, Malipedda Madhusairam, Raghunathan Radhakrishnan, Edathuruthy Kalarikal Arunpandiyan, Soundararajan Arnold, Vasumathi Jayaraj Indian J Nucl Med Case Report Somatostatin receptor-targeted alpha radionuclide therapies have been introduced including actinium-225 labeled tetraazacyclododecanetetraacetic acid–octreotide (Ac-225 DOTATATE) for advanced metastatic neuroendocrine tumors (NET). Very limited data are available on the posttherapy imaging using Ac-225 DOTATATE therapy in metastatic NET. We present Ac-225 single-photon emission computed tomography/computed tomography images of a 72-year-old patient diagnosed as a case of advanced rectal NET treated primarily with Ac-225 DOTATATE. Wolters Kluwer - Medknow 2020 2020-07-01 /pmc/articles/PMC7537929/ /pubmed/33082679 http://dx.doi.org/10.4103/ijnm.IJNM_58_20 Text en Copyright: © 2020 Indian Journal of Nuclear Medicine http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Case Report
Kamaleshwaran, Koramadai Karuppusamy
Suneelkumar, Malipedda
Madhusairam, Raghunathan
Radhakrishnan, Edathuruthy Kalarikal
Arunpandiyan, Soundararajan
Arnold, Vasumathi Jayaraj
Whole-body and Single-Photon Emission Computed Tomography/Computed Tomography Postpeptide Receptor Alpha Radionuclide Therapy Images of Actinium 225-Tetraazacyclododecanetetraacetic Acid–Octreotide as a Primary Modality of Treatment in a Patient with Advanced Rectal Neuroendocrine Tumor with Metastases
title Whole-body and Single-Photon Emission Computed Tomography/Computed Tomography Postpeptide Receptor Alpha Radionuclide Therapy Images of Actinium 225-Tetraazacyclododecanetetraacetic Acid–Octreotide as a Primary Modality of Treatment in a Patient with Advanced Rectal Neuroendocrine Tumor with Metastases
title_full Whole-body and Single-Photon Emission Computed Tomography/Computed Tomography Postpeptide Receptor Alpha Radionuclide Therapy Images of Actinium 225-Tetraazacyclododecanetetraacetic Acid–Octreotide as a Primary Modality of Treatment in a Patient with Advanced Rectal Neuroendocrine Tumor with Metastases
title_fullStr Whole-body and Single-Photon Emission Computed Tomography/Computed Tomography Postpeptide Receptor Alpha Radionuclide Therapy Images of Actinium 225-Tetraazacyclododecanetetraacetic Acid–Octreotide as a Primary Modality of Treatment in a Patient with Advanced Rectal Neuroendocrine Tumor with Metastases
title_full_unstemmed Whole-body and Single-Photon Emission Computed Tomography/Computed Tomography Postpeptide Receptor Alpha Radionuclide Therapy Images of Actinium 225-Tetraazacyclododecanetetraacetic Acid–Octreotide as a Primary Modality of Treatment in a Patient with Advanced Rectal Neuroendocrine Tumor with Metastases
title_short Whole-body and Single-Photon Emission Computed Tomography/Computed Tomography Postpeptide Receptor Alpha Radionuclide Therapy Images of Actinium 225-Tetraazacyclododecanetetraacetic Acid–Octreotide as a Primary Modality of Treatment in a Patient with Advanced Rectal Neuroendocrine Tumor with Metastases
title_sort whole-body and single-photon emission computed tomography/computed tomography postpeptide receptor alpha radionuclide therapy images of actinium 225-tetraazacyclododecanetetraacetic acid–octreotide as a primary modality of treatment in a patient with advanced rectal neuroendocrine tumor with metastases
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537929/
https://www.ncbi.nlm.nih.gov/pubmed/33082679
http://dx.doi.org/10.4103/ijnm.IJNM_58_20
work_keys_str_mv AT kamaleshwarankoramadaikaruppusamy wholebodyandsinglephotonemissioncomputedtomographycomputedtomographypostpeptidereceptoralpharadionuclidetherapyimagesofactinium225tetraazacyclododecanetetraaceticacidoctreotideasaprimarymodalityoftreatmentinapatientwithadvancedrectalneuroendocrinetumorwit
AT suneelkumarmalipedda wholebodyandsinglephotonemissioncomputedtomographycomputedtomographypostpeptidereceptoralpharadionuclidetherapyimagesofactinium225tetraazacyclododecanetetraaceticacidoctreotideasaprimarymodalityoftreatmentinapatientwithadvancedrectalneuroendocrinetumorwit
AT madhusairamraghunathan wholebodyandsinglephotonemissioncomputedtomographycomputedtomographypostpeptidereceptoralpharadionuclidetherapyimagesofactinium225tetraazacyclododecanetetraaceticacidoctreotideasaprimarymodalityoftreatmentinapatientwithadvancedrectalneuroendocrinetumorwit
AT radhakrishnanedathuruthykalarikal wholebodyandsinglephotonemissioncomputedtomographycomputedtomographypostpeptidereceptoralpharadionuclidetherapyimagesofactinium225tetraazacyclododecanetetraaceticacidoctreotideasaprimarymodalityoftreatmentinapatientwithadvancedrectalneuroendocrinetumorwit
AT arunpandiyansoundararajan wholebodyandsinglephotonemissioncomputedtomographycomputedtomographypostpeptidereceptoralpharadionuclidetherapyimagesofactinium225tetraazacyclododecanetetraaceticacidoctreotideasaprimarymodalityoftreatmentinapatientwithadvancedrectalneuroendocrinetumorwit
AT arnoldvasumathijayaraj wholebodyandsinglephotonemissioncomputedtomographycomputedtomographypostpeptidereceptoralpharadionuclidetherapyimagesofactinium225tetraazacyclododecanetetraaceticacidoctreotideasaprimarymodalityoftreatmentinapatientwithadvancedrectalneuroendocrinetumorwit

Ejemplares similares